NEUROCRINE BIOSCIENCES, INC. (NBIX) Total liabilities 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) total liabilities at each fiscal year-end, per SEC filings.
$1.4BFY2025 · since FY2016: $50.2M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +22.1% |
| FY2024 | $1.1B | +10.8% |
| FY2023 | $1.0B | +54.2% |
| FY2022 | $660.9M | -5.4% |
| FY2021 | $698.5M | +14.8% |
| FY2020 | $608.5M | -9.1% |
| FY2019 | $669.1M | +30.6% |
| FY2018 | $512.4M | +15.0% |
| FY2017 | $445.5M | +787.2% |
| FY2016 | $50.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice